PCM
MYOK

Prelude Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Prelude Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,348
Closed -$382K – 2321
2019
Q1 		$382K Buy
7,348
+7,088
+2,726% +$327K 0.02% 554
2018
Q4 		$13K Buy
260
+121
+87% +$6.66K ﹤0.01% 1330
2018
Q3 		$9K Sell
139
-173
-55% -$10.2K ﹤0.01% 1495
2018
Q2 		$15K Buy
+312
New +$15.1K ﹤0.01% 1413
2018
Q1 		– Sell
-11,122
Closed -$468K – 1816
2017
Q4 		$468K Sell
11,122
-2,710
-20% -$104K 0.04% 442
2017
Q3 		$593K Sell
13,832
-11,068
-44% -$353K 0.05% 335
2017
Q2 		$326K Buy
24,900
+24,700
+12,350% +$325K 0.03% 436
2017
Q1 		$3K Buy
+200
New +$2.56K ﹤0.01% 1444

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return